Virtual Library

• Volume 1
  
• Volume 2
  
• Volume 3
  
• Volume 4
  
• Volume 5
  
• Volume 6
  
• Volume 7
  
• Volume 8
  

About Cancer Therapy

ISSN print: 1543-9135; ISSN on-line: 1543-9143

The scope of Cancer Therapy is to rapidly publish original and in-depth review articles on cancer embracing all fields from molecular mechanisms to results on clinical trials. Articles (both invited and submitted) review or report novel findings of importance to a general audience in cancer therapy, molecular medicine, gene discovery, and molecular biology with emphasis to molecular mechanisms and clinical applications. The journal will accept papers on all aspects of cancer, at the clinical, preclinical or cell culture stage on chemotherapy and new experimental drugs, gene discovery, cancer immunotherapy, DNA vaccines, use of DNA regulatory elements in gene transfer, cell therapy and drug discovery related to cancer therapy.

Both review articles and original research articles will be considered. Original research articles should contain a generous introduction in addition to experimental data. The articles contain information important to a general audience as the volume is addressed also to researches outside the field. There is no limit on the length of the articles provided that the subject is interesting to a general audience and covers exhaustively a field. The typical length of each manuscript is 12-60 manuscript pages (approximately 4-20 printed pages) plus Figures and Tables.
Free of Charge publication, Complimentary reprints & Subscriptions

There are no page charges, no fees for color reproduction, and furthermore, authors receive 25 free reprints, a hard-bound issue containing their article, and an electronic format of their article that they can use in their personal website or to distribute freely to colleagues. Authors are also entitled to use Figures from their work originally published in Cancer Therapy in review articles for other journals by simply citing the original source.

The open electronic access to articles published in "Cancer Therapy" to a big general audience, the attractive journal title, the speed of the reviewing process, the no-charges for page numbers or color figure reproduction, the 25 complimentary reprints, the rapid electronic publication, the embracing of many fields in cancer, the anticipated high quality in depth reviews and first rate research articles and most important, the eminent members of the Editorial Board assembled are prognostic factors of a big success for the newly established journal

Citation in MedLine
If you have NIH funded research program your full article published in Gene Therapy & Molecular Biology or Cancer Therapy will appear on PubMed as full article freely accessible.
Articles accepted for publication by Cancer Therapy can be included in MedLine (PubMed) as full articles upon the request of authors provided that the authors have completed their published work under a government grant by NIH (or EU/Japan government grant). If this is your case, please consult the NIH Manuscript Submission System http://www.nihms.nih.gov/.

Cancer Therapy and Gene Therapy & Molecular Biology are Abstracted & Indexed in:

• Chemical Abstracts


• Directory of Open Access Journals
• (DOAJ)


• Open J-Gate


• HEAL-Link


• Genamics


• ExLibris


• EBSCO Host


• British Library Direct


• Hinari Access to Research Initiative

Furthermore, they are listed and electronically searchable in many libraries, institutes and universities worldwide, such as Karolinska Institute, Max Planck Institute, Geneva Foundation for Medical Education and Research, National Research Council of Canada, San Jose Public Libraries, California Digital Library, German Electronic Journals Library, Memorial University, Stanford University, Columbia University, University of Oslo, Kun Shan University (Taiwan), Charles Sturt University (Australia), OhioLink Library, Berkley Library and many more.